心房颤动的抗栓治疗 - Suppr

Suppr

超能文献

Antithrombotic treatment in atrial fibrillation.

作者信息

Kalra L, Lip G Y H

机构信息

Cardiovascular Division, King's College London School of Medicine, London, UK.

出版信息

Heart. 2007 Jan;93(1):39-44. doi: 10.1136/hrt.2006.099911. Epub 2006 Sep 4.

DOI:10.1136/hrt.2006.099911

PMID:16952971

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1861321/

Abstract

摘要

相似文献

Antithrombotic treatment in atrial fibrillation.

Heart. 2007 Jan;93(1):39-44. doi: 10.1136/hrt.2006.099911. Epub 2006 Sep 4.

Stroke risk assessment for atrial fibrillation: hospital-based stroke risk assessment and intervention program.

J Clin Pharm Ther. 2011 Feb;36(1):71-9. doi: 10.1111/j.1365-2710.2009.01156.x.

[Antithrombotic treatment in atrial fibrillation. Background to new recommendations and therapeutic alternative].

Lakartidningen. 2008;105(37):2478-80.

New anticoagulants for atrial fibrillation.

J Cardiovasc Med (Hagerstown). 2009 Jun;10(6):446-53. doi: 10.2459/JCM.0b013e3283249aee.

Atrial fibrillation: stroke prevention in older adults.

Clin Geriatr Med. 2012 Nov;28(4):617-34. doi: 10.1016/j.cger.2012.08.003.

Antithrombotic therapies for stroke prevention in atrial fibrillation.

Adv Neurol. 2003;92:249-56.

Stroke prevention in atrial fibrillation.

Cardiovasc Drugs Ther. 2011 Dec;25(6):561-70. doi: 10.1007/s10557-011-6334-4.

[Guidelines for antithrombotic therapy in atrial fibrillation: what the Italian Hemostasis and Thrombosis Society thinks].

Haematologica. 2001 Sep;86(9 Suppl):12-3.

Stroke prevention in atrial fibrillation patients.

Expert Opin Pharmacother. 2010 Oct;11(14):2331-50. doi: 10.1517/14656566.2010.498819.

Protecting the brain and the heart: antithrombotic treatment in nonvalvular atrial fibrillation.

Angiology. 2014 May;65(5):372-8. doi: 10.1177/0003319713486014. Epub 2013 Apr 25.

引用本文的文献

Atrial Fibrillation and Hypertension: Mechanistic, Epidemiologic, and Treatment Parallels.

Methodist Debakey Cardiovasc J. 2015 Oct-Dec;11(4):228-34. doi: 10.14797/mdcj-11-4-228.

Analysis of antithrombotic therapy after cardioembolic stroke due to atrial fibrillation or flutter.

Hosp Pharm. 2013 Feb;48(2):127-33. doi: 10.1310/hpj4802-127.

Clinical use of aspirin in treatment and prevention of cardiovascular disease.

Thrombosis. 2012;2012:245037. doi: 10.1155/2012/245037. Epub 2011 Nov 24.

Antithrombotic medication for cardioembolic stroke prevention.

Stroke Res Treat. 2011;2011:607852. doi: 10.4061/2011/607852. Epub 2011 Jun 22.

Incidence of atrial fibrillation in patients with either heart failure or acute myocardial infarction and left ventricular dysfunction: a cohort study.

BMC Cardiovasc Disord. 2011 May 14;11:19. doi: 10.1186/1471-2261-11-19.

Stroke prevention in the high-risk atrial fibrillation patient: Medical management.

Curr Cardiol Rep. 2011 Feb;13(1):9-17. doi: 10.1007/s11886-010-0148-z.

本文引用的文献

A differential effect of aspirin on prevention of stroke in atrial fibrillation.

J Stroke Cerebrovasc Dis. 1993;3(3):181-8. doi: 10.1016/S1052-3057(10)80159-4. Epub 2010 Jun 9.

Anticoagulant and antiplatelet therapy use in patients with atrial fibrillation undergoing percutaneous coronary intervention: the need for consensus and a management guideline.

Chest. 2006 Dec;130(6):1823-7. doi: 10.1378/chest.130.6.1823.

Bleeding risk stratification models in deciding on anticoagulation in patients with atrial fibrillation: a useful complement to stroke risk stratification schema.

Chest. 2006 Nov;130(5):1296-9. doi: 10.1378/chest.130.5.1296.

Additive role of plasma von Willebrand factor levels to clinical factors for risk stratification of patients with atrial fibrillation.

Stroke. 2006 Sep;37(9):2294-300. doi: 10.1161/01.STR.0000236840.00467.84. Epub 2006 Aug 3.

Trends in the prevalence of diagnosed atrial fibrillation, its treatment with anticoagulation and predictors of such treatment in UK primary care.

Heart. 2006 Aug;92(8):1064-70. doi: 10.1136/hrt.2005.069492. Epub 2005 Dec 30.

Hospitalized patients with atrial fibrillation and a high risk of stroke are not being provided with adequate anticoagulation.

J Am Coll Cardiol. 2005 Nov 1;46(9):1729-36. doi: 10.1016/j.jacc.2005.06.077. Epub 2005 Oct 10.

Antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks.

Cochrane Database Syst Rev. 2005 Oct 19;2005(4):CD001925. doi: 10.1002/14651858.CD001925.pub2.

Stroke prevention with aspirin, warfarin and ximelagatran in patients with non-valvular atrial fibrillation: a systematic review and meta-analysis.

Thromb Res. 2006;118(3):321-33. doi: 10.1016/j.thromres.2005.08.007. Epub 2005 Sep 29.

Antithrombotic treatment in atrial fibrillation.

Heart. 2006 Feb;92(2):155-61. doi: 10.1136/hrt.2005.066944. Epub 2005 Sep 13.

Asymptomatic atrial fibrillation: demographic features and prognostic information from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.

Am Heart J. 2005 Apr;149(4):657-63. doi: 10.1016/j.ahj.2004.06.032.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验